Menu
Not yet recruiting NCT07447674

ED Post-Discharge Digital Follow-Up: A Communication Comparison

No phase Interventional Emergency Department Overcrowding

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Standard Telephone Follow-Up, Enhanced Digital Communication Strategy.
Who it may be relevant to
Registry conditions: Emergency Department Overcrowding. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Comparison of Communication Strategies in Post-discharge Digital Reassessment of Patients Attended In-person in the Emergency Department. Back to Digital Study.

Overview

Emergency department overcrowding is a universal phenomenon associated with worse patient outcomes and a negative impact on healthcare teams. Telemedicine has been routinely implemented as a strategy to mitigate the harmful effects of overcrowding, particularly in pre-hospital assessments and triage processes. Since April 2024, the Emergency Care Units of Hospital Israelita Albert Einstein (HIAE) have offered low-risk patients-after nursing triage and in-person medical evaluation-the option of administrative discharge followed by digital reassessment via telemedicine. Currently, the initial communication strategy consists of an audio telephone call conducted by the telemedicine nursing team. In this study, we aim to test the hypothesis that the addition of alternative communication strategies may be associated with improved outcomes. This prospective, single-center, randomized, open-label pilot study will be conducted at a telemedicine center that serves five Emergency Care Units of HIAE. The study population will include patients aged 18 years or older who spontaneously seek care at an Emergency Care Unit, are classified as ESI 3, 4, or 5 during nursing triage, undergo in-person medical evaluation confirming low-risk status, and have complementary laboratory tests requested. Patients will be excluded if imaging exams are requested, if laboratory tests are expected to have a turnaround time exceeding 24 hours, or if they do not have access to a smartphone with WhatsApp and email for communication. After administrative discharge from the Emergency Department, patients will be randomized to one of two communication strategies: standard care, consisting of telephone contact by the telemedicine nursing team, or an incremental strategy, which includes instructions to check laboratory results via an application, reminder messages prompting patient-initiated contact through WhatsApp and email, and a telephone call in cases where no spontaneous contact occurs. The primary endpoint will be the time elapsed between medical discharge from the Emergency Care Unit and patient contact with HIAE.

Interventions

  • Behavioral Standard Telephone Follow-Up
    1. The telemedicine nursing team registers the patient in the telemedicine system and periodically checks the results of the requested laboratory tests. 2. A telephone call is made immediately after laboratory results become available. 3. If the initial call is unsuccessful, a second attempt is made after 2 hours.
  • Behavioral Enhanced Digital Communication Strategy
    1. Prior to discharge, patients are instructed to check their test results independently (via the "Meu Einstein" app) and to contact HIAE within a maximum of one hour after laboratory results become available. 2. Immediately after laboratory results become available, a WhatsApp message and an email are sent to the patient with instructions to contact HIAE. 3. An audio phone call is performed according to the standard protocol if no patient response occurs within 1 hour after results become avail

Primary outcome measures

  • Time to Telemedicine Contact After Emergency Department Discharge [Time frame: Within 24 hours after laboratory result availability.]
Secondary outcome measures (1)
  • Patient Satisfaction with Digital Reassessment Process (QAS-Tele Questionnaire) [Time frame: Within 48 hours after telemedicine reassessment.]

Eligibility criteria

Inclusion criteria

  • Age ≥ 18 years;
  • Initial in-person evaluation at the Emergency Care Unit of Hospital Israelita Albert Einstein;
  • Emergency Severity Index (ESI) classification of 3, 4, or 5 during nursing triage;
  • In-person medical evaluation confirming low-risk classification;
  • Request for complementary laboratory tests;
  • Acceptance of digital reassessment after discharge;
  • Provision of written informed consent.

Exclusion criteria

  • Request for blood culture testing;
  • Request for imaging studies (except chest X-ray evaluated in the Emergency Care Unit prior to discharge);
  • Laboratory tests with an expected turnaround time greater than 24 hours;
  • Change in clinical complexity level after medical evaluation;
  • Failure to transfer the discharged patient's identification to the Telemedicine Center;
  • Activation of a scheduled contingency plan at external units preventing timely patient registration in the telemedicine system as required by the program;
  • Lack of access to a smartphone with WhatsApp and email for communication.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Health services research

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07447674 · 85585724.2.0000.0071

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗